
Facade (Cannabis flos Synoptis Pharma): descendant of Apples and Bananas with a single source profile
Facade is a hybrid with lineage from Eye Candy and Apples and Bananas, supplied to Polish pharmacies by a single producer. We have gathered what has been documented about it and what has not been shown for it.
| Strain card | Facade |
|---|---|
| Producers | Synoptis Pharma (1 pharmacy position) |
| Medical brand | the same as the producer |
| Alternative names | none |
| Category by sources | hybrid with indica dominance |
| Leading terpene | limonene |
| Other terpenes | humulene caryophyllene linalool myrcene pinene |
| Lineage | established Eye Candy × Apples And Bananas |
| Source compliance | single source |
- Who supplies. Exclusively Synoptis Pharma, so there is nothing to compare versions with, and a supply break means no availability of this strain, not another version of it.
- Profile. Dominated by limonene, alongside humulene, caryophyllene, linalool, myrcene, and pinene. We do not provide percentage shares because sources calculate them against different totals.
- Origin. Established lineage, parents are Eye Candy and Apples And Bananas.
- What is missing. The profile describes a single source, so there is nothing to compare it with.
What is Facade and where does this strain come from?
Facade is a strain bred by Compound Genetics, resulting from the cross of Eye Candy with Apples and Bananas. This lineage is consistently reported by both Leafly and Seedfinder, with the latter linking it to the Alien Era series. In Polish pharmacies, it is a flower dispensed by a doctor’s prescription, in the Rpw category.
Both parents are cultivated strains, not landraces, so the lineage of Facade leads back to American seed selection, not to a specific cultivation region. Seedfinder attributes the line to the collaboration between Compound Genetics and Vertical Cannabis, explaining why the name appears in two catalogs simultaneously and is sometimes labeled with two breeding brands. However, what is more important for the reader is that the parents are named, so the origin does not need to be guessed from the commercial name.
Facade’s classification as a hybrid with indica-dominant traits comes from a single description and is worth as much as that. The division into indica and sativa describes the plant’s growth pattern in cultivation, not the effect of the raw material after administration, so the label from the catalog does not predict anything. The lineage speaks more here than that label, as it points to two specific parent strains that can be verified separately.
Which producers supply Facade to Polish pharmacies?
One. Facade reaches Polish pharmacies exclusively as flower from Synoptis Pharma, registered under a name that combines the producer with the declared content of active substances. Therefore, there is no second version of the same strain to compare it with, and any supply break immediately concerns the entire presence of this strain in the market.
| Producer | Raw material form | Dispensing mode | How this version differs |
|---|---|---|---|
| Synoptis Pharma | hemp flower in producer’s packaging | prescription, Rpw category | the only pharmacy version of Facade, so there is nothing to compare it with |
The declared THC content for this position ranges from 19.8-24.2%. A single number would be an overstatement of precision: the producer is responsible for compliance with the declaration within ten percent of its value, so a batch fully compliant with documentation can lie anywhere within that range. Comparing two strains based solely on nominal values thus compares labels, not raw material.
The composition of the list of available positions changes faster than the strain description. The permit for the raw material has an expiration date, deliveries can be suspended at the level of a single batch, and the producer can withdraw a position without notice. The current state shows a list of strains available in Polish pharmacies, not this description, because the strain description ages more slowly than the wholesaler’s stock. Separately, we also describe all positions of this producer.
It is worth distinguishing two products with similar names. Hemp flower available for retail sale does not belong to the Rpw category, is subject to different regulations, and is not a substitute for pharmacy raw material, even if the strain name sounds similar.
What does Facade smell and taste like?
- humulene humulene
- caryophyllene caryophyllene
- limonene limonene (leading in the pharmacy list)
- linalool linalool
- myrcene myrcene
- pinene pinene
The catalog describing this position lists five scent descriptors: citrus, fruity, peppery, piney, and herbal. This is a sensory description prepared by one commercial service, not a result of analysis, so we should read it as a tasting note: it tells what the authors of the description expected, not what laboratory measurement showed.
These descriptors can be translated into the profile composition, although the translation remains approximate. The citrus note corresponds to limonene, the piney to pinene, and the peppery to caryophyllene with humulene. Myrcene is often described as earthy or herbal, while linalool is described as floral. However, the nose does not determine the composition: the same scent can be produced by several compounds at once, and some positions in the profile do not have a distinct smell of their own.
The terpene profile of Facade describes a single source, the Polish commercial catalog, and lists humulene, caryophyllene, limonene, linalool, myrcene, and pinene. The leading position is limonene. We do not provide percentage shares because the denominator remains unknown: the same catalog assigns values to a greater number of positions than it lists in the profile itself, and the total shares reported by Polish databases for the same compositions are forty-six, seventy-three, and eighty-three percent. A number without a denominator looks in a drug text like a measurement, but it is not a measurement.
The smell of the flower and the smell of the vapor are two different things. Some compounds evaporate at lower temperatures than others, so the first inhalation carries a different profile than the last. This is compounded by storage: volatile components diminish from an opened package, so the same batch may smell weaker after a few weeks, although the content of active substances changes much more slowly.
How long does it take for Facade to take effect and how long does the effect last?
It is unknown, and this is not an excuse: no measurement of the duration of action for Facade has been published. Known ranges concern the method of administration, so the same portion will act differently when vaporized than when swallowed, regardless of which position from the pharmacy someone has in hand.
The route of administration determines the course more than the strain itself, and the ranges below describe it, not the cultivar, because pharmacokinetic studies for a single cultivar have not been published.
| Vaporization | After swallowing | |
|---|---|---|
| First sensations | after a few minutes | from half an hour to two |
| Onset | another ten to thirty minutes | slowly, over several hours |
| Total duration | within two to four hours | after six, sometimes eight hours |
| Typical error | none | taking a dose after thirty minutes, which gives both doses at once |
For a single pharmacy position, this means that an assessment recorded fifteen minutes after vaporization and an assessment recorded two hours after swallowing describe two different moments of the same course, not two different strains.
What has been shown and what has not been shown in studies on the composition of Facade?
Something has been shown about limonene, not about Facade itself. This cultivar has not been the subject of any published study, and available works concern a single compound administered to animals in doses and forms that do not correspond to what is dispensed in pharmacies as hemp flower in the producer’s packaging.
| Study | Model and route of administration | What was shown |
|---|---|---|
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Limonene administered intraperitoneally in mice showed muscle relaxant effects (rota-rod test) from a dose of 50 mg/kg and prolonged sleep induced by pentobarbital at a dose of 200 mg/kg (about 2.6 times); in the elevated plus maze test, already at a dose of 5 mg/kg, it reduced the number of entries into the open arms, which the authors described as an anxiogenic effect, not anxiolytic. |
| Fakhri S et al., 2025 Behavioural Pharmacology PMID:40622197 |
rodent (rat and mouse) | Limonene reduced paw swelling induced by carrageenan in rats and pain responses in the formalin test in mice; the effect was linked to the l-arginine/nitric oxide/cGMP/KATP channel pathway and involvement of opioid and benzodiazepine receptors. |
Both models are rodent-based, both concern a compound administered separately, outside the plant, so neither tells what Facade does to a patient. It is worth setting the boundary of this data directly. No anxiolytic effect of limonene has been shown in humans. It has also not been shown that isolated limonene has anxiolytic effects in animals; the only available data from the elevated plus maze test showed an opposite effect, reducing the number of entries into the open arms even at a low dose.
What side effects have been reported after Facade?
None specifically for this name. The reporting system links observation with a specific medicinal product and its batch number, not with the name of the cultivar, so there is no compilation that would describe symptoms after Facade differently than after any other hemp flower from a Polish pharmacy, regardless of the producer.
Reports of side effects are collected for the medicinal product with a batch number, not for the strain name, so the following concerns hemp flower as a group of raw materials. The most commonly reported are dry mouth, red eyes, and increased heart rate. Less frequently described are dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory, as well as anxiety increasing with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp flower in Poland do not separate them by individual products.
For Facade, even the simple market situation does not change this. The position is singular in pharmacies and comes from one producer, and public compilations do not go below the level of the entire group of raw material.
How to choose the vaporization temperature for the Facade profile?
There is no single correct value. The aromatic components of this profile boil over a range of more than one hundred degrees, from pinene at 156.2 degrees to caryophyllene at 257.5 degrees, so each setting evaporates some positions entirely and others only partially. The strain name does not indicate any number here.
| Profile component | Boiling point in PubChem database |
|---|---|
| pinene | 156.2 degrees Celsius, atmospheric pressure |
| myrcene | 166.8 degrees Celsius, atmospheric pressure |
| limonene | 177.8 degrees Celsius, atmospheric pressure |
| linalool | 195.5 degrees Celsius, atmospheric pressure |
| caryophyllene | 257.5 degrees Celsius, atmospheric pressure |
| humulene | no measurement at atmospheric pressure; the database notes 99.5 degrees Celsius at 3 mmHg |
The row for humulene shows why popular temperature tables can be incomparable. A measurement taken at reduced pressure gives a value significantly lower than what the same compound would achieve at ambient pressure, and online compilations mix both records in one column. Thus, the number for humulene compared to the rest of the table would suggest that it evaporates first, while in practice it comes down last.
The boiling point is also not a threshold below which nothing evaporates. Volatile compounds also transition to vapor at lower temperatures, just more slowly, so a setting lower than the number from the table still carries part of the profile. Additionally, the indication on the display describes the heater or chamber, not the raw material itself, and the difference between one and the other can be significant. We elaborate on this in a separate discussion on the evaporation of terpenes from flower and in the text about how the vaporizer setting differs from the temperature of the material.
Which strains are related to Facade?
| Strain | Common parent | Leading terpene | Producers |
|---|---|---|---|
| Gastro Pop | Apples And Bananas | myrcene | Four 20 Pharma |
One: Gastro Pop. Both derive from the same parent, Apples and Bananas, and both come from the breeding of Compound Genetics. There is no other position in Polish pharmacies sharing any of the parents with Facade, so the sibling in this graph ends with one entry.
Gastro Pop was created by crossing Apples and Bananas with Grape Gasoline and reaches pharmacies from another producer, Four 20 Pharma. Its profile leads with myrcene, not limonene, although both strains share the same parent. We describe it in a separate entry, along with the discrepancies between sources, which do not occur with Facade, as the latter is described by only one catalog.
A common parent does not predict a common composition, and a name does not predict kinship. The siblings of Gastro Pop also include two other pharmacy positions, Modified Gas and Pink Certz, but they are connected to it by the second parent, Grape Gasoline, which is not present in the lineage of Facade. From the perspective of Facade, they are therefore not siblings, but rather a distant kinship through one link, and the pedigree graph shows this more accurately than the similarity of commercial names. For Facade, this means one reference instead of a list, and this is a result of the graph, not a lack of data: the second parent, Eye Candy, has not appeared in the lineage of any other position currently available in Polish pharmacies.
Frequently asked questions about the Facade strain
Is Facade available without a prescription?
No. Facade belongs to the Rpw category, meaning it is a pharmaceutical raw material dispensed only by prescription under special control of circulation.
How many producers supply Facade to Polish pharmacies?
One, Synoptis Pharma. This is the only pharmacy version of this strain on the Polish market, so there is no second one to compare it with.
What components does the Facade profile mention?
Humulene, caryophyllene, limonene, linalool, myrcene, and pinene. The leading position is limonene, and all this composition comes from a single source.
Why is the THC content given as a range?
Because the producer is responsible for compliance with the declaration within ten percent of its value. For this position, this gives a THC content range of 19.8-24.2%, not a single number.
Does Facade have siblings among strains available in pharmacies?
Yes, one: Gastro Pop. Both strains share a common parent, Apples and Bananas, and both derive from the breeding of Compound Genetics.
Have studies been published on the Facade strain itself?
No. No studies have been published for this cultivar, and the works concerning limonene were conducted on rodents, not involving humans.
Hemp flower is a pharmaceutical raw material dispensed by a doctor’s prescription in the Rpw category. The material is informational in nature and does not replace medical consultation. Editorial text: editorial team ubucha.pl.







